BOMBELLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 9.672
EU - Europa 4.463
AS - Asia 1.491
SA - Sud America 22
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 15.687
Nazione #
US - Stati Uniti d'America 9.517
DE - Germania 933
IT - Italia 930
SE - Svezia 763
CN - Cina 736
IE - Irlanda 701
UA - Ucraina 398
HK - Hong Kong 280
GB - Regno Unito 228
SG - Singapore 220
CA - Canada 149
RU - Federazione Russa 132
FI - Finlandia 126
VN - Vietnam 83
FR - Francia 65
IN - India 65
DK - Danimarca 48
NL - Olanda 35
TR - Turchia 27
AT - Austria 26
ID - Indonesia 22
CZ - Repubblica Ceca 20
BE - Belgio 15
IR - Iran 15
RO - Romania 14
EU - Europa 11
BR - Brasile 10
JP - Giappone 10
AU - Australia 7
CH - Svizzera 7
KR - Corea 7
PE - Perù 5
ES - Italia 4
MY - Malesia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
BJ - Benin 3
LK - Sri Lanka 3
PL - Polonia 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
BB - Barbados 2
CM - Camerun 2
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
MG - Madagascar 2
MX - Messico 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MU - Mauritius 1
NP - Nepal 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 15.687
Città #
Ann Arbor 1.953
Woodbridge 944
Fairfield 824
Houston 758
Chandler 708
Dublin 665
Frankfurt am Main 660
Wilmington 485
Jacksonville 464
Ashburn 452
Dearborn 435
Seattle 360
New York 352
Hong Kong 276
Cambridge 268
Milan 263
Princeton 244
Nanjing 129
Altamura 122
Lawrence 117
Singapore 110
Shanghai 109
Beijing 103
Lachine 79
San Diego 76
Nanchang 52
Andover 43
Boardman 40
Guangzhou 39
Dong Ket 38
Fremont 38
Hebei 36
Helsinki 36
Shenyang 33
Falls Church 31
Lissone 31
Toronto 30
Tianjin 28
Vienna 25
Jiaxing 22
Nürnberg 20
Ottawa 20
Jinan 19
Kunming 19
London 19
Ningbo 19
Brno 18
Los Angeles 18
Monza 18
Norwalk 18
Rome 18
Changsha 17
Hangzhou 14
Jakarta 14
Lentate sul Seveso 14
Huizen 13
Brussels 12
Cinisello Balsamo 12
Philadelphia 12
Zhengzhou 12
Mountain View 11
Munich 11
Pune 11
Redmond 11
Auburn Hills 9
Bergamo 9
Sacramento 9
Washington 9
Edmonton 8
Hefei 8
Lappeenranta 8
Limbiate 8
Padova 8
Sesto San Giovanni 8
Turin 8
Amsterdam 7
Bonndorf 7
Desio 7
Genoa 7
New Delhi 7
Detroit 6
Lanzhou 6
Leawood 6
Moscow 6
Phoenix 6
San Mateo 6
Taizhou 6
University Park 6
Busto Arsizio 5
Carate Brianza 5
Caronno Varesino 5
Chicago 5
Cologno Monzese 5
Fuzhou 5
Hyderabad 5
Lima 5
Mcallen 5
Montréal 5
Pioltello 5
Saint Petersburg 5
Totale 12.083
Nome #
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 281
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 228
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 218
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 196
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 194
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 184
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 184
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 183
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 181
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 181
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 181
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 178
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 176
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 175
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 174
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 173
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 171
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 170
The Pamela study: main findings and perspectives 167
Differing associations for sport versus occupational physical activity and cardiovascular risk 166
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 163
The association between 24-h blood pressure patterns and left ventricular mechanics 162
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 161
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 161
Combined effects of hypertension and hypercholesterolemia on radial artery function 160
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 160
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 159
Role of ambulatory blood pressure monitoring in resistant hypertension 155
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 154
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 153
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 150
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 150
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 146
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 143
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 143
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 143
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 142
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 142
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 142
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 140
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 139
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 139
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 137
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 136
Should white-coat hypertension in diabetes be treated? Pro 134
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 134
HIV and metabolic syndrome - A comparison with the general population 133
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 133
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 133
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 132
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 130
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 129
Do reverse dippers have the highest risk of right ventricular remodeling? 129
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 128
The Pamela Study: Old and New Findings 125
Diurnal blood pressure variation and sympathetic activity 123
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 123
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 123
Diagnosis and management of patients with white-coat and masked hypertension 121
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 121
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 121
New-onset left atrial enlargement in a general population 121
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 119
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 117
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 117
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 117
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 116
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 116
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 115
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 115
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 114
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 113
Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population 111
Ambulatory blood pressure in air traffic controllers 111
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 111
Long-term risk of sustained hypertension in white-coat or masked hypertension 110
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 109
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) 108
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 108
Long-term changes in left ventricular mass echocardiographic findings from a general population 108
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 108
Predictive value of different indices of blood pressure variability on 107
Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population? 107
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 106
Seasonal variations in home and ambulatory blood pressure in the PAMELA population 105
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 104
Right heart remodeling induced by arterial hypertension: Could strain assessment be helpful? 103
The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? 103
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 102
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 101
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 101
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 101
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension 100
Hypertensive heart disease beyond left ventricular hypertrophy: Are we ready for echocardiographic strain evaluation in everyday clinical practice? 97
Arterial compliance in familial hypercholesterolaemia: A preliminary report 96
Uric acid and risk of new-onsetmetabolic syndrome, impaired fasting glucose and diabetesmellitus in a general Italian population: data from the Pressioni ArterioseMonitorate E Loro Associazioni study 94
Adverse prognostic value of persistent office blood pressure elevation in White coat Hypertension 92
Cardiovascular Risk Associated With White Coat Hypertension: Pro Side of the Argument. 92
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 91
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 90
Totale 13.669
Categoria #
all - tutte 56.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.820 325 128 202 220 283 385 403 210 259 172 165 68
2020/20212.352 141 119 225 254 202 203 219 225 185 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/202554 54 0 0 0 0 0 0 0 0 0 0 0
Totale 16.297